Strategic Outlook Dinner: Oncology Catalysts, Global BD Trends, and Policy Impacts in 2025

Overview

Join us on the eve of the ASCO Conference for an intimate dinner and timely discussion on the forces shaping the biopharma landscape in 2025.

Topics covered include an update on the biggest oncology catalysts for the rest of 2025, the evolution of partnering deals between large pharma and biotechs, with a special focus on a recent survey of China business development professionals.

We will also discuss the impact of tariffs on pharma, if any are announced, as well as the impact of DOGE cuts on the future of science in the US, and drug pricing.

This event will be on the record. 

Featured Speakers:

Sam Fazeli, Director of Research for Global Industries at Bloomberg Intelligence and Duane Wright, Bloomberg Intelligence Policy Analyst